Clinical Research Directory
Browse clinical research sites, groups, and studies.
Colchicine Use for Primary Prevention of Coronary Artery Disease
Sponsor: Qingdao Central Hospital
Summary
Colchicine has been widely used as an anti-gout medicine in the past decades. Some recent clinical trials have proved that low-dose colchicine can be used as a secondary prevention drug for coronary artery disease because of its anti-inflammatory mechanism. However, the effect on primary prevention has not been observed sufficiently. The objective of this study is to determine whether colchicine reduces the incidence of CAD in patients and its safety for long-term use.
Official title: Colchicine Use for Primary Prevention in People at High Risk of Coronary Artery Disease
Key Details
Gender
All
Age Range
40 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
6792
Start Date
2022-12-06
Completion Date
2028-07-01
Last Updated
2022-03-21
Healthy Volunteers
No
Conditions
Interventions
Colchicine
Colchicine 0.5mg/tablet
Placebo
matching placebo
Locations (1)
Mengmei Li
Qingdao, Shandong, China